5 months ago
17
ARTICLE AD BOX
(NewsNation) — Ro, an American telehealth company, has travel up with a solution to assistance diabetic patients looking for medications containing Glucagon-like peptide-1 (GLP-1) — similar Ozempic and Wegovy — amid a nationwide proviso shortage.
The institution created a free online tool that allows existent radical to study diabetes cause shortages successful their areas arsenic good arsenic study erstwhile they are successful stock. The tool, an interactive map, lights up with a yellowish lightning bolt each fewer seconds, indicating wherever users person reported GLP-1 medicine availability and shortages.
While these types of treatments are more accessible than they person been successful years prior, 1 misunderstanding astir them is that they’re casual to get.
Almost each dosages of the 4 marque names are listed arsenic “currently successful shortage” by the FDA. Eli Lilly, the pharmaceutical institution down Zepbound and Mounjaro, told NBC News supply issues could past into 2025.
Plus, roughly 15.5 cardinal U.S. adults use the medications arsenic weight nonaccomplishment drugs, meaning constricted availability is simply a apical issue.
